Golden State Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-45
Closed -$2.12K – 1750
2025
Q3
$2.12K Hold
45
– – ﹤0.01% 1383
2025
Q2
$2.17K Sell
45
-7
-13% -$358 ﹤0.01% 1349
2025
Q1
$2.88K Sell
52
-36
-41% -$1.95K ﹤0.01% 1268
2024
Q4
$4.29K Buy
+88
New +$4.47K ﹤0.01% 1145
2020
Q2
– Sell
-470
Closed -$21K – 814
2020
Q1
$21K Buy
+470
New +$22.5K 0.01% 496
2019
Q4
– Sell
-470
Closed -$22K – 785
2019
Q3
$22K Hold
470
– – 0.01% 602
2019
Q2
$20K Sell
470
-44
-9% -$1.87K 0.01% 620
2019
Q1
$23K Buy
+514
New +$22K 0.01% 594

Other funds holding SNY

Golden State Wealth Management's SNY Position: Q4 2025 in Review

Golden State Wealth Management sold out of Sanofi (SNY) in Q4 2025, closing a stake of 45 shares — an estimated $2.12K sold.

Golden State Wealth Management first reported a position in SNY in Q1 2019 and held it in 8 quarters. The position peaked at $23K in Q1 2019. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Golden State Wealth Management reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Golden State Wealth Management sold 45 Sanofi shares in Q4 2025, an estimated $2.12K.
  • Golden State Wealth Management first reported a position in Sanofi in Q1 2019 and held it in 8 quarters.
  • Golden State Wealth Management's Sanofi position peaked at $23K in Q1 2019.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Golden State Wealth Management's 13F filing for Q4 2025, filed 13 Feb 2026.